Cargando…
COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration
In April 2021, the US paused Janssen (J&J) COVID-19 vaccination because of reported blood clots post vaccination. This paper explores how vaccine decision-making--receiving a J&J vaccine right away vs waiting for a Pfizer vaccine--changed during the pause. In an opt-in internet-based survey...
Autores principales: | Wagner, Abram L., Zhang, Felicia, Kerekes, Stefania, Shih, Shu-Fang, Zhao, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477674/ https://www.ncbi.nlm.nih.gov/pubmed/37674932 http://dx.doi.org/10.1016/j.jvacx.2023.100373 |
Ejemplares similares
-
VITT REACTION ASSOCIATED WITH JOHNSON & JOHNSON COVID-19 VACCINE
por: AKUNA, MELANIE, et al.
Publicado: (2021) -
Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021) -
Johnson and Johnson COVID-19 Vaccination Triggering Pheochromocytoma Multisystem Crisis
por: Haji, Nahel, et al.
Publicado: (2021) -
ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine
por: Yadav, Rukesh, et al.
Publicado: (2022) -
Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population
por: Salmon, Daniel A., et al.
Publicado: (2022)